GB Patent

GB2337262A — Antiviral peptide derivatives

Assigned to F Hoffmann La Roche AG · Expires 1999-11-17 · 27y expired

What this patent protects

Compounds of general formula wherein E is -CHO or -B(OH) 2 , R<SP>9</SP> is a group connected via -(O)-CO- or -SO 2 -, R<SP>3</SP> and R<SP>6</SP> are H or lower alkyl (or R<SP>3</SP> is linked to R<SP>2</SP>) and the ot…

USPTO Abstract

Compounds of general formula wherein E is -CHO or -B(OH) 2 , R<SP>9</SP> is a group connected via -(O)-CO- or -SO 2 -, R<SP>3</SP> and R<SP>6</SP> are H or lower alkyl (or R<SP>3</SP> is linked to R<SP>2</SP>) and the other R groups are (substituted) hydrocarbyl, are viral proteinase inhibitors useful as antiviral agents for treatment or prophylaxis of infections caused by Hepatitis C or G, or human GB, viruses. Also claimed are acetal and (substituted) dioxaborolane derivatives of the above compounds.

Drugs covered by this patent

Patent Metadata

Patent number
GB2337262A
Jurisdiction
GB
Classification
—
Expires
1999-11-17
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.